L. Olsson et al., REGULATION OF RECEPTOR INTERNALIZATION BY THE MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I MOLECULE, Proceedings of the National Academy of Sciences of the United Statesof America, 91(19), 1994, pp. 9086-9090
We showed previously that peptides derived from the alpha 1 domain of
the major histocompatibility complex class I protein (MHC-I) inhibit i
nternalization of some receptors, thereby increasing the steady-state
number of active receptors on the cell surface. In consequence, sensit
ivity to hormone (e.g., insulin) is enhanced, transport (e.g., of gluc
ose by GLUT-4) is increased, and carrier proteins (e.g., transferrin)
operate less efficiently. Now we report that a bioactive peptide (but
not closely related inactive ones) binds to MHC-I on the cell surface,
not in the groove but apparently to the alpha 1 helix. The binding is
saturable, and the number of peptide binding sites on the cell surfac
e approximately equals the number of MHC-I molecules. Antibodies to MH
C-I inhibit peptide binding. Most significant, antibodies to MHC-I mim
ic the effect of a bioactive peptide, inhibiting receptor internalizat
ion. These results indicate that MHC-I participates in the regulation
of cell surface receptor activity.